KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Cash from Investing Activities (2016 - 2026)

Medtronic's Cash from Investing Activities history spans 12 years, with the latest figure at -$816.0 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities rose 3.2% year-over-year to -$816.0 million; the TTM value through Jan 2026 reached -$2.5 billion, down 16.99%, while the annual FY2025 figure was -$1.9 billion, 18.13% up from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$816.0 million at Medtronic, down from -$482.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $271.0 million in Q2 2022 and bottomed at -$1.6 billion in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$490.0 million (2025), against an average of -$587.0 million.
  • The largest annual shift saw Cash from Investing Activities soared 84.24% in 2022 before it crashed 275.28% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.1 billion in 2022, then soared by 63.0% to -$424.0 million in 2023, then rose by 18.63% to -$345.0 million in 2024, then tumbled by 39.71% to -$482.0 million in 2025, then tumbled by 69.29% to -$816.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Cash from Investing Activities are -$816.0 million (Q1 2026), -$482.0 million (Q4 2025), and -$719.0 million (Q3 2025).